AzTrials
AzTrials

Facial Nerve PalsyEarly Phase 1SESPLNCT06895902

Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy

A Early Phase 1 study testing Polypropylene Suture Eyelid Spring for Paralytic Lagophthalmos in people with Facial Nerve Palsy and Corneal Exposure, run by University of Alberta at 2 sites in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The eyelids protect the cornea and eyelid closure is essential to ocular health and clear vision. Patients with permanent Bells palsy or facial nerve palsy from other reasons such as tumours or trauma may be unable to blink and protect their cornea. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Polypropylene Suture Eyelid Spring for Paralytic Lagophthalmos
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
2 sitesCanada
Study dates
28 Apr 2025to 31 Jul 2028
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults 18 years of age or older with facial nerve transection or paralytic lagophthalmos that has not improved after 6 weeks.

Who cannot join

  • Patients unable to tolerate awake eyelid surgery under local anesthetic.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Edsel B Ing, MD PhD FRCSC MPH MIAD MEd MBA contact

6472930155 ext. 780) 735-8784

ed.ing@ualberta.ca

Canada2 sites, 2 recruiting
  • Eye Institute of Alberta, Royal Alexandra Hospital

    Edmonton, Alberta, T5H 3V9

    Edsel B Ing, MD PhD, 780) 735 8784, ed.ing@ualberta.ca

    Erin MM&E Childs, 780) 735 8784, erin.childs@ahs.ca

    Not yet recruiting
  • Eye Institute of Alberta, Royal Alexandra Hospital

    Edmonton, Alberta, T5J 0N3

    Edsel Ing, MD PhD FRCSC MPH MEd MIAD MBA, 16472930155, ed.ing@ualberta.ca

    Rita Whitford, whitford@ualberta.ca

    Recruiting

Other trials in Canada

About this study

Official title: Suture Eyelid Spring for Eyelid Closure in Patients With Facial Nerve Palsy

The eyelids protect the cornea and eyelid closure is essential to ocular health and clear vision.

Patients with permanent Bells palsy or facial nerve palsy from other reasons such as tumours or trauma may be unable to blink and protect their cornea.

Read more

Irreversible visual loss can occur if the cornea is not kept lubricated.

Current treatment options for patients whose eyelid blink does not recover include lubricating the eye every hour or two with drops and lubricating ointment at night, patching the eye closed, sewing parts of the eyelid together (tarsorrpahy), upper lid gold weight or a dental wire spring.

It is inconvenient to lubricate the cornea constantly, and the lubricating drops and ointment usually cost more than $80.00 per month. Lubrication often blurs vision, because the patient must look through a film.

Patching the eye closed and tarsorraphy deprives the patient of peripheral vision, can impede social interaction, and is objectionable cosmetically.

Upper-lid gold weights can be placed underneath the eyelid skin and work by gravity. A gold weight will only work when the patient initiates a forced blink. Gold weights may not work when the patient is lying down because there is no gravity to assist lid closure. The eyelid skin is the thinnest skin in the body and can extrude through the skin over time.

Eyelid springs made of metal dental wire exist but are not frequently used because they often extrude through the thin eyelid skin. Also, dental wire springs require attachment to the bone near the side of the eye. It is not uncommon that dental wire springs have to be removed or replaced.

The investigators propose a new spring to close the eyelid made out of the surgical stitches (sutures) commonly used in medicine and eyelid surgery. The stitch will be made into a custom shape and attached underneath the skin near the centre of the lid, without attachment to the bone.

Upper lid gold weights, dental wire springs, and our proposed suture spring are all foreign bodies and can all become infected or extrude through the skin. Because the suture spring is thinner than a gold weight and because it does not have sharp edges like a metal spring, there should be less risk of extrusion. The suture spring will lose its elasticity over time and will require replacement.

Read the detailed description

PURPOSE: To develop and test a plastic lid spring to help patients with facial nerve palsy who cannot close their eyes (paralytic lagophthalmos) and protect their cornea.

HYPOTHESIS: Polypropylene monofilament suture (Prolene) is Health Canada-approved and commonly used in surgery including surgery in the eyelid region. When the prolene suture is coiled in a loop it has elastic spring that can assist in lid closure. If the prolene loop coil is sutured to the tarsus and underneath the orbital septum inferior to the superior orbital rim, it should help keep the eyelid closed, while still allowing the levator and Mullers muscles to open the lid.

JUSTIFICATION: Current methods to help patients with paralytic lagophthalmos require improvement. Tarsorraphy decreases peripheral vision and adversely affects cosmesis. Gold weights are static and require a forced blink and gravity to work. Gold weights may not help when the patient is supine. Wire lid springs require suturing or fixation to the lateral orbital bone and extensive dissection. The thin dental wire frequently extrudes through the skin.

In contrast to the above a plastic suture lid spring would be placed in the central lid with less dissection than a dental wire spring, and about the same amount of dissection as a gold weight. As the plastic has innate elasticity it provides dynamic lid closure whether the patient is upright or supine.

OBJECTIVES AND METHOD:

  1. FORCE DETERMINATION The amount of force required to close the lids is estimated by F=m*g, where m is in the range of 1.2 to 1.4 grams and g is 9.81 m/s^2. The investigators will measure the dynamic force of 10 mm compression on the prolene suture. Ten mm is the sum of normal vertical palpebral fissure height (margin reflex distance 1 and margin reflex distance 2.) Prolene suture loops of calibres from 5-0 to 2 will be tested in a mechanical engineering laboratory. Since humans may blink 12 times per minute of the waking day, repetitive strain tests will be performed to determine the longevity of the plastic spring.
  2. CADAVER STUDY The cadavers will be accessed through the University of Alberta anatomy lab, general surgery anatomy service and used in keeping with the intent of the donors and donor families. The investigators will not be collecting identifiers. A 2 mm deep incision will be made in the upper eyelid, 2 centimeters in length. The investigators will place the prolene suture in the cadaver lid underneath the septum superiorly and suture to the tarsus inferiorly. The cadaver study will allow optimal determination of the anatomic placement of the suture for human studies. The prolene loop can be custom-sized for the wound bed and tied to itself once the desired size is achieved.
  3. HUMAN STUDIES

Patients with lagophthalmos will have short to long-term placement of the prolene loop. Because of the local anesthetic, and bleeding and bruising, approximately 1 month will be required to determine if the prolene loop is beneficial, or whether it should be removed and a gold weight implanted instead. During this 1 month the patient with paralytic lagophthalmos is not at any increased risk of corneal exposure than during their pre-operative state and should maintain their corneal lubrication.

As there are only a limited number of patients with paralytic lagophthalmos, further testing can be performed on ptosis patients undergoing anterior levator Patients with anterior ptosis repair will have temporary placement of the lid spring, and blink dynamics will be observed. Note that patients requiring ptosis repair have the same anatomic dissection as required for the plastic spring. The placement of the prolene spring will in no way harm the result of the ptosis surgery. The prolene plastic spring will be placed for about 2 minutes to observe blink dynamics and removed and the ptosis surgery will proceed as usual.

In the patients with paralytic lagophthalmos. Pre-operative lagophthalmos in mm, House-Brackman score for facial nerve impairment, visual acuity, corneal status, corneal sensation, Bells phenomenon, lid contour and cosmesis, will be recorded. The same measurements will be repeated at the post-operative 1 week, 1-month, 2-month, 6-month, and 12-month checks.

PLAN FOR DATA ANALYSIS

Paired t-tests will be used to compare the pre-operative and 1-month post-operative results, and then to compare the 1 month with the 6-month results.

The investigators will monitor the patients over a 12-month period to see if the lid spring loses elasticity or has wound complications.

Being tested
Polypropylene Suture Eyelid Spring for Paralytic Lagophthalmos
Keywords
Paralytic lagophthalmos
Medical subject headings
Bell Palsy, Lagophthalmos

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Polypropylene Suture Eyelid Spring for Paralytic LagophthalmosDevice

    The polypropylene loop eyelid suture spring will be centrally placed without fixation to the bone unlike a metal lid spring.

Study groups in NCT06895902
Study groupRoleWhat they receive
Placement of suture lid springExperimentalInstead of tying tissue with the surgical suture (polypropylene) that is normally used in lid surgery we will make a loop out of the suture and place it underneath the eyelid skin to see if it will help with eyelid closure in patients with facial nerve palsy. There is no placebo or comparison group
Receives: Device: Polypropylene Suture Eyelid Spring for Paralytic Lagophthalmos

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary outcome

    Amount of lid closure in millimetres

    Measured: within the first 2 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2025
  2. Study start28 Apr 2025
  3. Primary completion31 Jul 2028 (estimated)
  4. Study completion31 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Model description
non-masked surgical intervention
Masking
None (open label)
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06895902
Sponsor's protocol ID
Pro00149272
Acronym
SESPL
Status last verified
May 2026
First submitted
24 Feb 2025
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Polypropylene Suture Eyelid Spring for Paralytic Lagophthalmos in people with Facial Nerve Palsy and Corneal Exposure, run by University of Alberta at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Edsel B Ing, MD PhD FRCSC MPH MIAD MEd MBA (6472930155 ext. 780) 735-8784, ed.ing@ualberta.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary outcome (time frame: within the first 2 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in